Nowak-Sliwinska P - Search Results

1

Identification of a Synergistic Multi-Drug Combination Active in Cancer Cells via the Prevention of Spindle Pole Clustering.

Weiss A, Le Roux-Bourdieu M, Zoetemelk M, Ramzy GM, Rausch M, Harry D, Miljkovic-Licina M, Falamaki K, Wehrle-Haller B, Meraldi P, Nowak-Sliwinska P. Weiss A, et al. Cancers (Basel). 2019 Oct 22;11(10):1612. doi: 10.3390/cancers11101612. Cancers (Basel). 2019. PMID: 31652588 Free PMC article.

2

Angiostatic kinase inhibitors to sustain photodynamic angio-occlusion.

Nowak-Sliwinska P, Weiss A, van Beijnum JR, Wong TJ, Ballini JP, Lovisa B, van den Bergh H, Griffioen AW. Nowak-Sliwinska P, et al. J Cell Mol Med. 2012 Jul;16(7):1553-62. doi: 10.1111/j.1582-4934.2011.01440.x. J Cell Mol Med. 2012. PMID: 21880113 Free PMC article.

3

Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalization.

Weiss A, van Beijnum JR, Bonvin D, Jichlinski P, Dyson PJ, Griffioen AW, Nowak-Sliwinska P. Weiss A, et al. J Cell Mol Med. 2014 Mar;18(3):480-91. doi: 10.1111/jcmm.12199. Epub 2014 Jan 22. J Cell Mol Med. 2014. PMID: 24450440 Free PMC article.

4

Rapid optimization of drug combinations for the optimal angiostatic treatment of cancer.

Weiss A, Ding X, van Beijnum JR, Wong I, Wong TJ, Berndsen RH, Dormond O, Dallinga M, Shen L, Schlingemann RO, Pili R, Ho CM, Dyson PJ, van den Bergh H, Griffioen AW, Nowak-Sliwinska P. Weiss A, et al. Angiogenesis. 2015 Jul;18(3):233-44. doi: 10.1007/s10456-015-9462-9. Epub 2015 Apr 1. Angiogenesis. 2015. PMID: 25824484 Free PMC article.

5

A streamlined search technology for identification of synergistic drug combinations.

Weiss A, Berndsen RH, Ding X, Ho CM, Dyson PJ, van den Bergh H, Griffioen AW, Nowak-Sliwinska P. Weiss A, et al. Sci Rep. 2015 Sep 29;5:14508. doi: 10.1038/srep14508. Sci Rep. 2015. PMID: 26416286 Free PMC article.

6

Optimization of drug combinations using Feedback System Control.

Nowak-Sliwinska P, Weiss A, Ding X, Dyson PJ, van den Bergh H, Griffioen AW, Ho CM. Nowak-Sliwinska P, et al. Nat Protoc. 2016 Feb;11(2):302-15. doi: 10.1038/nprot.2016.017. Epub 2016 Jan 14. Nat Protoc. 2016. PMID: 26766116 Free article.

7

Current Trends in Multidrug Optimization: An Alley of Future Successful Treatment of Complex Disorders.

Weiss A, Nowak-Sliwinska P. Weiss A, et al. SLAS Technol. 2017 Jun;22(3):254-275. doi: 10.1177/2472630316682338. Epub 2016 Dec 27. SLAS Technol. 2017. PMID: 28027446 Review.

8

Current Trends in Multidrug Optimization.

Weiss A, Nowak-Sliwinska P. Weiss A, et al. J Lab Autom. 2016 Dec 1:2211068216682338. doi: 10.1177/2211068216682338. Online ahead of print. J Lab Autom. 2016. PMID: 28095178

9

Combination of ruthenium(II)-arene complex [Ru(η⁶-p-cymene)Cl₂(pta)] (RAPTA-C) and the epidermal growth factor receptor inhibitor erlotinib results in efficient angiostatic and antitumor activity.

Berndsen RH, Weiss A, Abdul UK, Wong TJ, Meraldi P, Griffioen AW, Dyson PJ, Nowak-Sliwinska P. Berndsen RH, et al. Sci Rep. 2017 Feb 22;7:43005. doi: 10.1038/srep43005. Sci Rep. 2017. PMID: 28223694 Free PMC article.

10

Epigenetic approach for angiostatic therapy: promising combinations for cancer treatment.

Berndsen RH, Abdul UK, Weiss A, Zoetemelk M, Te Winkel MT, Dyson PJ, Griffioen AW, Nowak-Sliwinska P. Berndsen RH, et al. Angiogenesis. 2017 May;20(2):245-267. doi: 10.1007/s10456-017-9551-z. Epub 2017 Apr 4. Angiogenesis. 2017. PMID: 28378227 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page